Article Information
History
- March 30, 2022.
Article Versions
- Version 1 (March 12, 2022 - 14:01).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chuanqi Sun1,†,
- Kang Zhou2,†,
- Peter DePaola IV1,3,
- Woo Shik Shin4,
- Trae Hillyer4,
- Michael R. Sawaya3,
- Z. Hong Zhou2 and
- Lin Jiang1,*
- 1Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA
- 2California Nano Systems Institute, UCLA, Los Angeles, CA 90095, USA
- 3Departments of Biological Chemistry and Chemistry and Biochemistry, Howard Hughes Medical Institute, UCLA-DOE Institute, UCLA, Los Angeles, CA 90095, USA
- 4Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, OH 44272, USA
- ↵*For correspondence:
Lin Jiang, email: jianglin{at}ucla.edu
↵† These authors contributed equally to this work.
Posted March 30, 2022.
Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation
